Characteristics Of Genetic Predisposition To The Development Of Juvenile Idiopathic Arthritis In Children.
Keywords:
juvenile rheumatoid arthritis, diagnostics, prognosisAbstract
The article presents clinical laboratory features and prognostic criteria of juvenile rheumatoid arthritis. The clinical characteristics of the disease and the results of laboratory analysis are important in choosing an effective treatment method. Medicinal and surgical treatment of joints is recommended, depending on the severity of the disease, the characteristics of the clinical flow and the results of the functional laboratory analysis.
References
Wikipedia. Recombinant DNA. http:/en.wikipedia.org/wiki/Recombinant_DNA
Nelson PN, Reynolds GM, Waldron EE et al. Monoclonal antibodies. Mol Pathol 2000;53(3):111–7.
Wikipedia. Fusion protein. http://en.wikipedia.org/wiki/Fusion_protein
Woo P. Cytokines and juvenile idiopathic arthritis. Curr Rheumatol Rep 2002;4(6):452–7.
Bazzoni F., Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med
;334(26):1717–25.
Scott DL, Kingsley GH Tumor necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med
;355(7):704–12.
Beutler BA The role of tumor necrosis factor in health and disease. J Rheumatol Suppl 1999;57:16 –21.
McDevitt H., Munson S., Ettinger R., Wu A. Multiple roles for tumor necrosis factor-alpha and
lymphotoxin alpha/beta in immunity and autoimmunity. Arthr Res 2002;4(Suppl. 3 ):S 141–S152.
Sfikakis PP, Kollias G. Tumor necrosis factor biology in experimental and clinical arthritis. Curr Opin
Rheumatol 2003;15(4):380–6.
Dekker L., Armbrust W., Rademaker CM et al. Safety of anti- TNFalpha therapy in children with
juvenile idiopathic arthritis. Clin Exp Rheumatol 2004;22(2):252–8.
Wilkinson N., Jackson G., GardnerMedwin J. Biologic therapies for juvenile arthritis. Arch Dis Child
;88(3):186–91.
Lovell DJ, Giannini EH, Reiff A. et al. Etanercept in children with polyarticular juvenile rheumatoid
arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000;342(11):763–9.
Lovell DJ, Giannini EH, Reiff A. et al. Long-term efficacy and safety of etanercept in children with
polyarticularcourse juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label,
extended-treatment trial. Arthr Rheum 2003;48(1):218–26.
Lovell DJ, Reiff A, Jones OY et al. Long-term safety and efficacy of etanercept in children with
polyarticular-course juvenile rheumatoid arthritis. Arthr Rheum 2006;54(6):1987–94.
Lovell DJ, Reiff A, Ilowite NT et al. Safety and efficacy of up to eight years of continuous etanercept
therapy in patients with juvenile rheumatoid arthritis. Arthr Rheum 2008;58(5):1496–504.
Giannini EH, Ilowite NT, Lovell DJ et al. Long-term safety and effectiveness of etanercept in children
with selected categories of juvenile idiopathic arthritis. Arthr Rheum 2009;60(9):2794–804.
Horneff G., Schmeling H., Biedermann T. et al. The German etanercept registry for treatment of juvenile
idiopathic arthritis. Ann Rheum Dis 2004;63(12):1638–44.
Horneff G., De Bock F., Foeldvari I. et al. Safety and efficacy of combination of etanercept and
methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA):
preliminary data from the German JIA Registry. Ann Rheum Dis 2009;68(4):519–25.
Quartier P., Taupin P., Bourdeaut F. et al. Efficacy of etanercept for the treatment of juvenile idiopathic
arthritis according to the onset type. Arthr Rheum 2003;48(4):1093–101.
Eberhard BA, Ilowite NT Response of systemic onset juvenile rheumatoid arthritis to etanercept: is the
glass half full or half empty? J Rheumatol 2005;32(5):763–521. Bobomuratov , T.A., Nurmatova , N.F., Sultanova , N.S., Mallaev , S.S., & Fayziev , N.N. (2022).
Brestfeeding and Genetic Features of Juvenile Rheumatoid Arthritis. Journal of Pharmaceutical Negative
Results, 1983-1988.
Mallaev Sh.Sh , Bobomuratov TA, Fayziev NN, Sultanova NS, Dinmuxammadieva DR Genetic
Aspects of Juvenile Rheumatoid Arthritis. ISSN (E): 2795 – 7624 VOLUME 10 | JULY 2022. 1-5.
Mallaev Sh.Sh, Alimov A.V. Comparative effectiveness of traditional therapy and chronotherapy in
the treatment of juvenile rheumatoid arthritis. // New day in medicine - 2020. - T. 1. No. 1 - P. 258-262.
Mallaev Sh.Sh, Alimov A.V. Clinical course of juvenile rheumatoid arthritis and its treatment
optimization // journal "Pediatrics" No. 2 Tashkent 2020. P. 200-203.
Mallaev Sh . Sh ., Alimov A . IN . Clinical course of juvenile rheumatoid arthritis and its treatment
optimization // Tibbiyotda yangi kun . – 2020. - №4 (32). – P. 68-71. (14.00.00. - No. 22) .
Mallaev Sh.Sh. , Alimov AV Clinic - laboratory manifestation of juvenile rheumatoid arthritis //
European vestnik pediatrii . – 2020. - No. 3 – P. 56-60.
Mallaev Sh.Sh. Modern features of the course of clinical variants of juvenile rheumatoid arthritis //
Interuniversity Scientific Congress "Higher School: Scientific Research" Moscow, 2020. - P. 64-65.
Mallaev Sh.Sh. Justification of the chronopharmacological approach to the treatment of diffuse
connective tissue diseases in children // Interuniversity Scientific Congress "Higher School: Scientific
Research" Moscow, 2020. - P. 66-67.
Mallaev Sh.Sh., Alimov A.V. Functional state of the adrenal glands in children with juvenile rheumatoid
arthritis // Collection of articles based on the materials of the XXXI international scientific and practical
conference No. 1 (28) Moscow 2020. - P. 76-80.
Mallaev Sh.Sh., Alimov A.V. New approaches to the treatment of juvenile rheumatoid arthritis //
Collection of articles based on the materials of the XXXI international scientific and practical conference
No. 2 (62) Moscow 2020. - P. 18-22 .
Rakhmankulova Z. Zh., Kamalov Z. S. Genetic predictors of the occurrence of hypoxic -ischemic
encephalopathy in newborn children // Journal of Theoretical and Clinical Medicine. - 2020. - No. 4. - P.
-101.
Muxtorov MG, Yunusova RT Bolalarda C ovid-19 dan keyings davrda biriktiruvchi to'qimaning tizimli
kasalliklarining laborator va clinic xususiyatlari // Journal of Academic Research of New Uzbekistan. –
– T. 1. – No. 6. – pp. 33-35.
Muxtorov M. et al. Biriktiruvchi to' qimaning tizimli kasalliklari bor bolalarda Covid-19 ning uchrash
chastotasi //Theoretical aspects in the formation of pedagogical sciences. – 2024. – T. 3. – No. 10. – S. 149-
Tilloeva , Sh Sh., Fayziyev N N. , "DIAGNOSTIC CRITERIA OF OSTEARTHROSIS IN PATIENTS
OF SENIOR AGE GROUPS." EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE 2.9
(2022): 73-77.
Fayziev, N. N., Mallaev , Sh. Sh., Sultanova, N. S., & Bobomuratov , T. A. Changes in the hemostasis
system in children with pneumonia and optimization of their treatment. Academic Research in Educational
Sciences Volume 4 | Special Issue 1 | 2023 ISSN: 2181-1385
Fayziev, N. N., Latipova , Sh. A. , NERVE SYSTEMASINING PERINATAL SHIKASTLANISH
FONIDAGI OBSTRUCTIVE BRONCHITIS BOLALARDA IMMUNOLOGIK UZGARISHLAR
Student Bulletin. No. 42 (140), Part 6, 2020. P. 98-101
Bobomuratov T. A., Fayziev N. N., Mallaev Sh. Sh. Coronavirus infections in children, clinical features,
diagnostics, treatment in children. Bulletin Tashkent medical academy № 5 2022. P. 21-23
Mallaev Sh. Sh., Fayziev N. N., et al. Features of the clinical course of coronavirus infection in children
(literature review) // JOURNAL OF HEPATO-GASTROENTEROLOGICAL RESEARCH. - 2022. - No.
SI-2.
Sultanova , NS, Avezova , GS, Mallaev , SS, & Fayziyev , NN //COMPREHENSIVE
CHARACTERISTICS OF THE STATE OF HEALTH OF CHILDREN IN DIFFERENT AGE PERIODS,
DEPENDING ON THE TYPES OF FEEDING AND CARE //British Medical Journal. – 2023. – T. 3. –
No. 2.40. N.N. Fayziev , Sh.Sh. Mallaev , N.S. Sultanova, T.A. Bobomuratov // Changes in the system hemostasis
in children with pneumonia and optimization their treatment //Academic research in educational sciences,
No. 1 P 180-187
Mallaev Sh Sh , NS Sultanova , GS Avezova , NN Faiziev . //Molecular-Genetic Mechanisms of the
Development of Juvenile Idiopathic Arthritis in Children./ / Texas Journal of Medical Science. – 2023 31-
TA Bobomuratov , NN Fayziev GENETIC FEATURES OF THE HEMOSTASIS SYSTEM IN
CHILDREN WITH PNEUMONIA Bulletin of the Tashkent Medical Academy No. 9 2023. P. 29-30
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
